Folic acid/lactobacillus casei Disease Interactions
There are 2 disease interactions with folic acid / lactobacillus casei.
Folic acid (applies to folic acid/lactobacillus casei) anemia
Major Potential Hazard, High plausibility. Applicable conditions: Anemia of Unspecified Nutritional Deficiency
The use of folic acid is contraindicated in patients with undiagnosed anemia. Folic acid in dosages above 1 mg/day can obscure the diagnosis of pernicious anemia by alleviating the hematologic abnormalities while allowing the progression of neurologic complications. In addition, folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.
References (3)
- Butterworth CE Jr, Tamura T (1989) "Folic acid safety and toxicity: a brief review." Am J Clin Nutr, 50, p. 353-8
- Katz M (1973) "Potential danger of self-medication with folic acid." N Engl J Med, 289, p. 1095
- "Product Information. Renal Multivitamin Formula Rx (folic acid)." Vitaline Corporation, Ashland, OR.
Probiotics (applies to folic acid/lactobacillus casei) immunosuppression
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Immunodeficiency
Probiotics, especially those containing lactobacillus, should be used with caution in immunosuppressed patients.
References (3)
- "Product Information. Culturelle DS (lactobacillus rhamnosus GG)." ConAgra Functional Foods
- Salminen MK, Tynkkynen S, Rautelin H, et al. (2002) "Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland." Clin Infect Dis, 35, p. 1155-60
- Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK (2005) "Lactobacillus sepsis associated with probiotic therapy." Pediatrics, 115, p. 178-81
Switch to consumer interaction data
Folic acid/lactobacillus casei drug interactions
There are 374 drug interactions with folic acid / lactobacillus casei.
Folic acid/lactobacillus casei alcohol/food interactions
There is 1 alcohol/food interaction with folic acid / lactobacillus casei.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.